• Sunday, Jul 12, 2020
  • Last Update : 07:14 pm

India approves emergency use of remdesivir to treat Covid-19 patients

  • Published at 08:25 am June 3rd, 2020
Remdesivir
File photo: An ampule of remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues Reuters

The approval comes a day after the US drugmaker reported that remdesivir showed modest benefit in patients with moderate Covid-19

India’s government said on Tuesday it has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use for five doses in treating Covid-19 patients.

Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in Covid-19 patients in formal clinical trials and is at the forefront of the battle against Covid-19, which has no approved treatment or vaccine.

The drug was granted emergency use authorization by the US Food and Drug Administration last month and has received approval by Japanese health regulators. The drug is being administered in some countries under compassionate use rules.

“(Remdesivir) approved on June 1 under emergency use with condition for five dose administration,” the Drugs Controller General of India said in an email statement.

The approval comes a day after the US drugmaker reported that remdesivir showed modest benefit in patients with moderate Covid-19 given a five-day course, while those who received it for 10 days in the study did not fare as well.

The drug has been approved for the treatment of adults and children with severe Covid-19, the Indian Express newspaper reported on Tuesday, citing sources.

The regulator has decided against extending the use of the drug to 10 days, based on existing evidence presented to it at the time of approval, according to the paper.

Gilead did not respond to an email seeking further details.

The company signed non-exclusive licensing pacts last month with five generic drugmakers based in India and Pakistan, including Cipla Ltd and Jubilant Life Sciences Ltd, to expand supply of the drug.

As of Tuesday, India has 198,706 cases of coronavirus and has recorded 5,598 deaths, health ministry data showed.

Governments are racing to bolster supplies of remdesivir, with European and South Korean authorities vying for the potential Covid-19 treatment.

53
52
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail